» Articles » PMID: 36672091

Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers-A Prospective, Cross-Sectional, Multi-Center Analysis

Abstract

Spinal muscular atrophy (SMA) is a disabling disease that affects not only the patient’s health-related quality of life (HRQoL), but also causes a high caregiver burden (CGB). The aim of this study was to evaluate HRQoL, CGB, and their predictors in SMA. In two prospective, cross-sectional, and multi-center studies, SMA patients (n = 39) and SMA patient/caregiver couples (n = 49) filled in the EuroQoL Five Dimension Five Level Scale (EQ-5D-5L) and the Short Form Health Survey 36 (SF-36). Caregivers (CGs) additionally answered the Zarit Burden Interview (ZBI) and the Hospital Anxiety and Depression Scale (HADS). Patients were clustered into two groups with either low or high HRQoL (EQ-5D-5L index value <0.259 or >0.679). The latter group was mostly composed of ambulatory type III patients with higher motor/functional scores. More severely affected patients reported low physical functioning but good mental health and vitality. The CGB (mean ZBI = 22/88) correlated negatively with patients’ motor/functional scores and age. Higher CGB was associated with a lower HRQoL, higher depression and anxiety, and more health impairments of the CGs. We conclude that patient and CG well-being levels interact closely, which highlights the need to consider the health of both parties while evaluating novel treatments.

Citing Articles

The Socio-Economic Burden of Spinal Muscular Atrophy: A Cost-of-Illness Study in Bulgaria.

Dzhambazova E, Kostadinov K, Tsenkova-Toncheva L, Galabova F, Ezeldin F, Iskrov G Healthcare (Basel). 2025; 13(4).

PMID: 39997276 PMC: 11855038. DOI: 10.3390/healthcare13040401.


Longitudinal Efficacy of Nusinersen Treatment on Health-Related Quality of Life and Independence in Children With Later-Onset Spinal Muscular Atrophy.

Huang S, Jiang L, Zhou D, Yan Y, Feng Y, Yu Y Muscle Nerve. 2024; 71(3):368-376.

PMID: 39718202 PMC: 11799406. DOI: 10.1002/mus.28311.


The Impact of Comorbidities and Motor Impairment on the Quality of Life of Patients with Spinal Muscular Atrophy: A Case-Control Study.

Blauciak M, Ubysz J, Pokryszko-Dragan A, Koszewicz M J Clin Med. 2024; 13(14).

PMID: 39064224 PMC: 11277901. DOI: 10.3390/jcm13144184.


Health-related quality of life of adults with spinal muscular atrophy: insights from a nationwide patient registry in Germany.

Landfeldt E, Leibrock B, Hussong J, Thiele S, Walter M, Moehler E Qual Life Res. 2024; 33(7):1949-1959.

PMID: 38753126 DOI: 10.1007/s11136-024-03665-5.


[Recent research on home rehabilitation and nursing for spinal muscular atrophy].

Leng M, Peng H, Wu Z Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(4):420-424.

PMID: 38660908 PMC: 11057298. DOI: 10.7499/j.issn.1008-8830.2310037.


References
1.
Baranello G, Darras B, Day J, Deconinck N, Klein A, Masson R . Risdiplam in Type 1 Spinal Muscular Atrophy. N Engl J Med. 2021; 384(10):915-923. DOI: 10.1056/NEJMoa2009965. View

2.
Lins L, Carvalho F . SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016; 4:2050312116671725. PMC: 5052926. DOI: 10.1177/2050312116671725. View

3.
Ware Jr J . SF-36 health survey update. Spine (Phila Pa 1976). 2000; 25(24):3130-9. DOI: 10.1097/00007632-200012150-00008. View

4.
Ludwig K, von der Schulenburg J, Greiner W . German Value Set for the EQ-5D-5L. Pharmacoeconomics. 2018; 36(6):663-674. PMC: 5954069. DOI: 10.1007/s40273-018-0615-8. View

5.
Burke T, Hardiman O, Pinto-Grau M, Lonergan K, Heverin M, Tobin K . Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads. J Neurol. 2018; 265(4):793-808. DOI: 10.1007/s00415-018-8770-6. View